SP-02L

· Solasia Pharma K.K.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for SP-02L, covering 2014-09-04 to 2024-01-26. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 2 Study of SP-02L in Patients With Relapsed or Refractory Peripheral T-cell Lymphoma (PTCL) [Phase 2]